Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
– Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models...
Dr. Coral Posert of Implant Dentistry Vacaville Explains How Convenience, Transparency, and Personalization Are Redefining Dentistry